Physician profile
Bruce Hillard
NPI 1407851678
$2,499.37
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,450 · 2020: $1,050.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $311.21 | 2019-2020 | |
| Novo Nordisk INC | $287.59 | 2019-2020 | |
| Allergan, INC. | $265.60 | 2019-2020 | |
| Amarin Pharma, INC. | $217.75 | 2019-2020 | |
| Pfizer INC. | $201.76 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $180.82 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $175.63 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $164.13 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $126.30 | 2019-2020 | |
| Amgen INC. | $124.94 | 2019-2020 | |
| Lilly USA, LLC | $64.54 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $62.76 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $53.70 | 2019-2020 | |
| Abbvie INC. | $49.38 | 2019 | |
| Sanofi-Aventis U.S. LLC | $46.24 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $44.67 | 2019 | |
| Glaxosmithkline, LLC. | $37.78 | 2019-2020 | |
| Corcept Therapeutics | $36.31 | 2020 | |
| Ironshore Pharmaceuticals INC. | $16.43 | 2020 | |
| Hikma Pharmaceuticals USA | $16.02 | 2019 | |
| Ironwood Pharmaceuticals, INC | $15.81 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Hillard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.